Home Multimedia Podcasts Four-Stranded DNA May Aid in Developing Targeted Cancer Therapies Four-Stranded DNA May Aid in Developing Targeted Cancer Therapies September 22, 2016 Quadruple helices appear to have role in switching genes on or off. /wp-content/uploads/2018/09/SoundsOfScience_Sterling-9_22_16.mp3 Cancer therapyCellular, Molecular and Developmental BiologyDNAMedicine, Diagnosis, and TherapeuticsMolecular biologyNucleic acidsTherapeutics Also of Interest 10x Ships First Single Cell GEM-X Assays to Customers StockWatch: Blockbuster Sales Projected for Madrigal MASH Drug Machine Learning Can Spot Tumor-Reactive TCRs, Speed Immunotherapies Epstein-Barr Virus Has Vulnerable Sites Exposed 89bio’s MASH Drug Begins Phase III, Aiming to Stand Out in Growing Field Curio Begins Testing Commercial Spatial Barcoding Technology for Single Cell Sequencing Related Media Carl Icahn States His Case for Change at Illumina on "Close to the Edge" Celebrating DNA Day: An Interview with Eric Green on "The State of Genomics" Celebrating DNA: Matthew Cobb's Reflections on the Double Helix Emerging Markets Collaborate to Succeed in Post-Pandemic World The Sun Sets on AGBT: A Report from the Last Day Spatial, Sequencing, and Sun: A Report from Day 2 of AGBT Related Content 10x Ships First Single Cell GEM-X Assays to Customers StockWatch: Blockbuster Sales Projected for Madrigal MASH Drug Machine Learning Can Spot Tumor-Reactive TCRs, Speed Immunotherapies Epstein-Barr Virus Has Vulnerable Sites Exposed